Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells
By H. Niwa, J. Miyazaki, Austin G Smith. Nature Genetics, 2000
3,854 citations recorded by the source corpus.
Subfields: Molecular Biology
View Paper: https://www.semanticscholar.org/paper/95cfc59760d98b9d80a2efd6a439bbb5b02ee1b9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- Richard A. Young
- S. Yamanaka
- K. Hochedlinger
- G. Keller
- R. Jaenisch
- David P. Bartel
- H. Niwa
- Kathrin Plath
Citations in the corpus
- Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. (2006, background): “Consistent with this idea, a mere 50% increase or decrease in Oct3/4 proteins induces differentiation of ES cells (Niwa et al., 2000). iPS clones overexpressed the four factors when RNA levels were analyzed,buttheirproteinlevels werecomparabletothosein…”
- Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation. (2005, positive): “…(Tx)-inducible Cdx2, Cdx2ER, was introduced into ZHBTc4 ES cells, in which both of the endogenous Oct3/4 alleles are disrupted and a tetracycline (Tc)-regulable Oct3/4 transgene is expressed to maintain self-renewal (Niwa et al., 2000), resulting in the establishment of the ES cell line 4CER1.”
- Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. (2003, background): “The dosage effect indicated for Nanog is also a feature of Oct-4 (Niwa et al., 2000) and Stat3 (Niwa et al.”
- Oct4-induced pluripotency in adult neural stem cells. (2009, positive): “These studies of the developing embryo were complemented by studies of ESCs in which the Oct4 function was abolished (Niwa et al., 2000).”
- An extended transcriptional network for pluripotency of embryonic stem cells. (2008, background): “Indeed, the dosage of Oct4 is crucial: reduced expression permit trophoectoderm development, whereas enhanced expression drives primitive endoderm differentiation (Niwa et al., 2000).”
- The Polycomb Group Protein Suz12 Is Required for Embryonic Stem Cell Differentiation (2007, background): “In any event, it would be extremely interesting to know if the differentiation defects of Suz12 / ES cells depend on lack of Nanog and/or Oct4 repression; however, this experiment is unfortunately not feasible because ES cells do not grow in the absence of the two transcription factors (25, 29).”
- Statistical confidence estimation for Hi-C data reveals regulatory chromatin contacts (2014, background): “10A), consistent with these genes’ roles as master regulators in undifferentiated ESCs regulating the maintenance of developmental potency (Niwa et al. 2000; Mitsui et al. 2003).”
- HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. (2006, background): “As dose-dependent functions of Oct-4 in ES cells have previously been described (Scholer et al. 1990b; Niwa et al. 2000), we hypothesized that aberrant Oct-4 expression accounted for the low number of post-implantation Hif-2 KI/KI embryos recovered in our experiments, as well as their morphological ”
- c-Myc regulates transcriptional pause release (2010, methodology): “For location analysis following Oct4 shutdown, ZHBTc4 mES cells (Niwa et al., 2000) were grown under standard mES cell culture conditions and expanded for two passages off MEF feeders.”
- Strategies and new developments in the generation of patient-specific pluripotent stem cells. (2007, background): “Suppression of Oct-3/4 resulted in spontaneous differentiation into the trophoblast lineages in both mouse (Niwa et al., 2000) and human ES cells (Zaehres et al., 2005).”